DE60024843D1 - Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten - Google Patents

Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten

Info

Publication number
DE60024843D1
DE60024843D1 DE60024843T DE60024843T DE60024843D1 DE 60024843 D1 DE60024843 D1 DE 60024843D1 DE 60024843 T DE60024843 T DE 60024843T DE 60024843 T DE60024843 T DE 60024843T DE 60024843 D1 DE60024843 D1 DE 60024843D1
Authority
DE
Germany
Prior art keywords
liposomes
vaccines
nucleic acid
oral use
use contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024843T
Other languages
English (en)
Other versions
DE60024843T2 (de
Inventor
Gregory Gregoriadis
Yvonne Perrie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipoxen Technologies Ltd
Original Assignee
Lipoxen Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipoxen Technologies Ltd filed Critical Lipoxen Technologies Ltd
Application granted granted Critical
Publication of DE60024843D1 publication Critical patent/DE60024843D1/de
Publication of DE60024843T2 publication Critical patent/DE60024843T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60024843T 1999-10-01 2000-10-02 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Expired - Lifetime DE60024843T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99307786 1999-10-01
EP99307786 1999-10-01
PCT/GB2000/003773 WO2001024773A1 (en) 1999-10-01 2000-10-02 Liposome-entrapped dna oral vaccines

Publications (2)

Publication Number Publication Date
DE60024843D1 true DE60024843D1 (de) 2006-01-19
DE60024843T2 DE60024843T2 (de) 2006-08-10

Family

ID=8241653

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024843T Expired - Lifetime DE60024843T2 (de) 1999-10-01 2000-10-02 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten

Country Status (11)

Country Link
US (1) US7008791B1 (de)
EP (1) EP1217989B1 (de)
JP (1) JP2003529550A (de)
KR (1) KR100744237B1 (de)
CN (1) CN1196474C (de)
AT (1) ATE312599T1 (de)
AU (1) AU7540500A (de)
CA (1) CA2386024A1 (de)
DE (1) DE60024843T2 (de)
ES (1) ES2256043T3 (de)
WO (1) WO2001024773A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1519745B1 (de) 2002-07-05 2006-12-20 Lipoxen Technologies Limited Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
US20060286161A1 (en) * 2003-05-09 2006-12-21 Steffen Panzner Injectable liposomal depots for delivering active ingredients
JP4255396B2 (ja) * 2004-03-19 2009-04-15 津田駒工業株式会社 水噴射式織機の水受け装置
WO2008077413A1 (es) * 2006-12-22 2008-07-03 Soluciones Biotecnologicas Innovacion Ltda Vacunas adn en peces
WO2008114274A1 (en) * 2007-03-19 2008-09-25 Fresenius Kabi Onclology Ltd. Proliposomal and liposomal compositions
CN101940321B (zh) * 2010-08-06 2012-06-20 南昌大学 动态高压微射流-冻融法制备中链脂肪酸纳米脂质体
CN101940320B (zh) * 2010-08-06 2012-08-29 南昌大学 薄膜分散-动态高压微射流制备中链脂肪酸纳米脂质体
EP2708134A1 (de) 2012-09-17 2014-03-19 Unilever N.V. Teigzusammensetzungen umfassend eine strukturierte Fettphase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2305157T3 (es) * 1996-09-13 2008-11-01 Lipoxen Technologies Limited Liposomas.
FR2760193B1 (fr) * 1997-02-28 1999-05-28 Transgene Sa Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules

Also Published As

Publication number Publication date
JP2003529550A (ja) 2003-10-07
DE60024843T2 (de) 2006-08-10
EP1217989B1 (de) 2005-12-14
CN1376056A (zh) 2002-10-23
WO2001024773B1 (en) 2001-08-16
CN1196474C (zh) 2005-04-13
KR20030011763A (ko) 2003-02-11
CA2386024A1 (en) 2001-04-12
EP1217989A1 (de) 2002-07-03
ES2256043T3 (es) 2006-07-16
KR100744237B1 (ko) 2007-07-30
AU7540500A (en) 2001-05-10
ATE312599T1 (de) 2005-12-15
WO2001024773A1 (en) 2001-04-12
US7008791B1 (en) 2006-03-07

Similar Documents

Publication Publication Date Title
US11185480B2 (en) Buffered microencapsulated compositions and methods
WO2003030934A3 (en) Cpg formulations and related methods
HUP0302114A2 (hu) Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása
US5665374A (en) Ultramulsion containing interdental delivery devices
ATE198040T1 (de) Feste fettnanoemulsionen als wirkstoffabgabevehikel
ATE355826T1 (de) Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten
ATE186212T1 (de) Geschmacksmaskierte pharmazeutische mittel
DE60119693D1 (de) Tensidfreietopische zusammensetzungen und verfahren zur schnelle herstellung davon
HUP9802445A2 (hu) Liposzómás oligonukleotid készítmények és eljárás human RAF kifejeződésének gátlására
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
HUP0402451A3 (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
AU2001295671A1 (en) Pharmaceutical composition for immunisation against aids
DE60024843D1 (de) Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten
WO2002056900A3 (de) Verwendung von slpi zur behandlung chronisch-entzündlicher darmerkrankungen
ATE234919T1 (de) Antisense nukleinsäuren zur vorbeugung und behandlung von beschwerden in welchen die exprimierung von c-erbb-2 eine rolle spielt
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
ATE285239T1 (de) Dna enthaltende impfstoffen
FR2819175B1 (fr) Composition cosmetique et/ou dermatologique acide contenant un polymere amphiphile
US5733529A (en) Ultramulsion based antigingivitis toothpaste compositions
EP1248650B1 (de) Verbesserte dns impfstoffe für rinder-herpes virus 1
WO2001082892A3 (de) Wirkstoffhaltige liposome
WO2003101482A3 (en) Liposome vaccine formulations for fin-fish
DE69018702D1 (de) Verfahren zur Herstellung eines Antikaries-Impfstoffes aus Streptococcus mutans und Impfzusammensetzung gegen Karies in Form von Nasentropfen.
CA2334520A1 (en) Treatment of immune diseases
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition